AGI.do

Products

What will AGI do for Electroconvulsive devices?

In this classification, this commodity indicates a product that that is used in a psychiatric treatment in which seizures are electrically induced in patients to provide relief from psychiatric illnesses. US FDA regulates Electroconvulsive devices under 21 CFR 882.5940 and under FDA product code GXC. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

How AGI delivers it

Four ways AGI delivers for Electroconvulsive devices

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Electroconvulsive devices, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Electroconvulsive devices, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Electroconvulsive devices connects

measured by

  • Charge Deliveredmodel
  • Output Amperagemodel
  • Pulse Widthmodel
  • Seizure Durationmodel

Go deeper

Explore Electroconvulsive devices

Read the deeper take on agi.asView as markdown